Rare diseases
Investigational molecules
Locations
Back to Poland1 clinical trial in Oława, Poland. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)PolandThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical trials focusing on atherosclerotic cardiovascular disease (ASCVD) are evaluating novel therapeutic approaches for patients whose current lipid-modifying treatments aren't providing optimal results.
These studies aim to assess new treatment options for reducing cardiovascular events including heart attacks, strokes, and the need for emergency coronary procedures.
Research initiatives are exploring the effectiveness of novel lipid-modifying compounds in patients with established cardiovascular conditions who require additional therapeutic options.
The trials focus on evaluating treatments that could potentially improve outcomes for patients with arterial plaque buildup.
Studies are underway examining interventions for atherosclerotic disease management, particularly focusing on patients who haven't achieved optimal results with existing treatments.
This research aims to expand treatment options for patients with cardiovascular conditions requiring enhanced therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
